Kathy Jo Usher

Kathy Jo Usher, MA, MBA, currently serves as the Director of Corporate Accounts and Trade at Acrotech Biopharma, INC since April 2024. Prior to this role, Usher held various positions at TerSera Therapeutics, including National Accounts Director for the Acute Care Division and National Director of Reimbursement, from September 2020 to April 2024. Usher also worked at Lexicon Pharmaceuticals, Inc. as Director of Strategic Accounts, focusing on the Carcinoid Syndrome therapeutic category, and at Bayer Pharmaceuticals as Deputy Director of Channel Strategy and Marketing for Health Plans and PBMs, where strategies for managed markets were developed. Usher’s early career includes a tenure at Schering-Plough Pharmaceuticals, where positions included Senior Regional Account Manager and Senior District Sales Manager. Usher's academic credentials include an MA and MBA in International Management Studies from Naveen Jindal School of Management at UT Dallas, complemented by a Graduate Certificate in Executive and Professional Coaching.